Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
38,426,331
-
Share change
-
-1,109,896
-
Total reported value
-
$313,265,401
-
Put/Call ratio
-
160%
-
Price per share
-
$8.15
-
Number of holders
-
124
-
Value change
-
-$31,639,128
-
Number of buys
-
60
-
Number of sells
-
62
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q4 2017
As of 31 Dec 2017,
CYTOKINETICS INC - COMMON STOCK (CYTK) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,426,331 shares.
The largest 10 holders included
BlackRock Inc., BVF INC/IL, Vanguard Group Inc, STATE STREET CORP, LANSDOWNE PARTNERS (UK) LLP, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, WASATCH ADVISORS INC, PINNACLE ASSOCIATES LTD, and CITIGROUP INC.
This page lists
126
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.